Buzz surrounding the drug retatrutide continues to grow, as the medication shows dramatic results in clinical trials for type 2 diabetes , obesity , and other health conditions. Retatrutide is not yet approved by the U.S. Food and Drug Administration (FDA) for use, but a growing body of research suggests it may have a range of potential uses. Results from two new phase 3 clinical trials present retatrutide as a potential future treatment for knee osteoarthritis . The data shows that for people with overweight or obesity, retatrutide can significantly ease knee pain, and even eliminate it in some…

Read the full article at EVERYDAYHEALTH.COM